Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to -$0.35.

  • Regenerative Medical Technology's EPS (Weighted Average and Diluted) fell 40000.0% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.56, marking a year-over-year decrease of 3333.33%. This contributed to the annual value of -$0.44 for FY2024, which is 2336.46% up from last year.
  • Regenerative Medical Technology's EPS (Weighted Average and Diluted) amounted to -$0.35 in Q3 2025, which was down 40000.0% from -$0.1 recorded in Q2 2025.
  • Regenerative Medical Technology's 5-year EPS (Weighted Average and Diluted) high stood at $0.01 for Q4 2022, and its period low was -$0.82 during Q3 2021.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.08 (2024), whereas its average is -$0.15.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 10413.28% in 2022, then plummeted by 20344880.29% in 2023.
  • Over the past 5 years, Regenerative Medical Technology's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.14 in 2021, then surged by 104.13% to $0.01 in 2022, then tumbled by 2628.16% to -$0.14 in 2023, then soared by 64.1% to -$0.05 in 2024, then tumbled by 586.32% to -$0.35 in 2025.
  • Its last three reported values are -$0.35 in Q3 2025, -$0.1 for Q2 2025, and -$0.06 during Q1 2025.